Investing
Figuring out how to invest your money to generate consistent returns can seem daunting, especially if you don’t have extensive financial knowledge. Our investing section provides novice investors with the key strategies and tips for how to invest money wisely. We deliver actionable advice to help you build wealth steadily over time.
Simply put, investing as a beginner can look confusing initially. But sticking to proven, time-tested investing principles can help you avoid costly mistakes and accumulate real returns. We believe successful investing doesn’t require taking excessive risk. By learning how to assess risk vs reward and allocating capital prudently, regular investors can steadily build wealth over the long run.
From setting investment goals and building a diversified portfolio to rebalancing and maximizing returns, we cover the essential investing basics. You’ll learn timeless wisdom from legendary investors like Warren Buffett and Peter Lynch that can guide your own investment decisions. We explain key terms and concepts clearly, so you can grasp investing fundamentals quickly.
While investing always involves some degree of risk, going in with the right knowledge helps tilt the odds in your favor. We believe the average individual has the ability to invest successfully on their own and grow significant wealth over time. By teaching you how to invest money wisely, we aim to empower our readers to take control of their financial futures.
Ready to start growing your money? Browse our investing for beginners articles covering stocks, mutual funds, ETFs, real estate, and alternative assets. Learn how to open a brokerage account, build a portfolio, and invest with a long-term mindset. Sign up for our free investing newsletter to get simple money tips delivered to your inbox daily.
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Bristol Myers BMY recently announced that a late-stage study, seeking to expand the label of its cancer combination drug, Opdivo (nivolumab) and Yervoy (ipilimumab), ...
Three Reasons to Retain Integer Holdings (ITGR) Stock for Now
Integer Holdings Corporation ITGR has been gaining from its research and product development activities. The optimism led by a solid first-quarter 2024 performance and ...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Shares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for ...
Disney’s (DIS) New Film Rules the Box Office With $129M Opening
Disney’s DIS Kingdom of the Planet of the Apes, the latest installment in the iconic Planet of the Apes series, stormed the weekend box ...
3 Audio Video Stocks Worth Watching in a Flourishing Industry
The Zacks Audio Video Production industry participants are concentrating on the premium segment of the branded products market for business growth. Dolby Laboratories DLB. ...
What’s in Store for Toll Brothers’ (TOL) in Q2 Earnings?
Toll Brothers, Inc. TOL is scheduled to report second-quarter fiscal 2024 (ended Apr 30, 2024) results on May 21, after the closing bell. In ...
Wall Street Analysts Think Cartesian Therapeutics, Inc. (RNAC) Could Surge 141%: Read This Before Placing a Bet
Shares of Cartesian Therapeutics, Inc. (RNAC) have gained 9.2% over the past four weeks to close the last trading session at $21.17, but there ...
3 Auto Firms to Watch on Stock Buyback Bonanza
Companies frequently employ stock buybacks or share repurchase programs to bolster shareholder value. These initiatives involve firms purchasing their own outstanding shares. This effectively ...
Lazard’s (LAZ) April AUM Declines 3.8% on Weaker Markets
Lazard, Inc. LAZ reported its preliminary asset under management (AUM) balance of $240.8 billion for April 2024. This reflected a 3.8% decline from $250.4 ...
Boot Barn Holdings (BOOT) to Post Q4 Earnings: What’s in Store?
Boot Barn Holdings, Inc. BOOT is poised to face a decline in its top-line performance as it prepares to unveil its fourth-quarter fiscal 2024 ...















